Mariana Pinto
January 31, 2024

Owlpharma becomes a member of the 3PARL

Owlpharma is proud to announce that it has joined the 3PARL, new Third-Party Audit Report Library (3PARL®) consortium, led by Rephine and Eurofins Healthcare.

Today's challenges in ensuring the compliance throughout the pharmaceutical supply chain demonstrate the clear need to define ethical and quality standards that protect the integrity of auditing services. Aligned with the consortium's mission to establish a global benchmark for ethical manufacturing supply chain audits, we considered essential to join the project and we look eager to contribute to its definition.

The members of the 3PARL consortium are committed to ensuring a consistent high standard of GMP supply chain auditing in the pharmaceutical industry. Read more about the 3PARL HERE

Latest news

April 15, 2024


Alexandra Miranda

New Decree-Law for Medical Devices in Portugal

April 8, 2024


Lígia Ferreira

Environmental Risk Assessment - The long-awaited updated guideline

March 12, 2024


Raquel Miguéis

Latest news on Advertisement of Medicinal Products in Digital Channels in Portugal